{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:57:23Z","timestamp":1786982243739,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The transjugular intrahepatic portal collateral-systemic shunt (transcollateral TIPS) is used to treat portal hypertension-related complications in patients with cavernous transformation of the portal vein (CTPV) and whose main portal vein cannot be recanalized. It is still not clear whether transcollateral TIPS can be as effective as portal vein recanalization\u2013transjugular intrahepatic portosystemic shunt (PVR\u2013TIPS). This study aimed to evaluate the efficacy and safety of transcollateral TIPS in the treatment of refractory variceal bleeding with CTPV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with refractory variceal bleeding caused by CTPV were selected from the database of consecutive patients treated with TIPS in Xijing Hospital from January 2015 to March 2022. They were divided into the transcollateral TIPS group and the PVR\u2013TIPS group. The rebleeding rate, overall survival, shunt dysfunction, overt hepatic encephalopathy (OHE) and operation-related complications were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 192 patients were enrolled, including 21 patients with transcollateral TIPS and 171 patients with PVR\u2013TIPS. Compared with the patients with PVR\u2013TIPS, the patients with transcollateral TIPS had more noncirrhosis (52.4 vs. 19.9%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002), underwent fewer splenectomies (14.3 vs. 40.9%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.018), and had more extensive thromboses (38.1 vs. 15.2%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.026). There were no differences in rebleeding, survival, shunt dysfunction, or operation-related complication rates between the transcollateral TIPS and PVR\u2013TIPS groups. However, the OHE rate was significantly lower in the transcollateral TIPS group (9.5 vs. 35.1%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.018).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Transcollateral TIPS is an effective treatment for CTPV with refractory variceal bleeding.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12072-023-10522-z","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T02:02:35Z","timestamp":1682388155000},"page":"979-988","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Transjugular intrahepatic collateral-systemic shunt is effective for cavernous transformation of the portal vein with variceal bleeding"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3669-0467","authenticated-orcid":false,"given":"Jun","family":"Tie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuangye","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xulong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyuan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"issue":"2","key":"10522_CR1","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jhep.2021.04.029","volume":"75","author":"M Senzolo","year":"2021","unstructured":"Senzolo M, Garcia-Tsao G, Garcia-Pagan JC. Current knowledge and management of portal vein thrombosis in cirrhosis. J Hepatol. 2021;75(2):442\u2013453","journal-title":"J Hepatol"},{"issue":"6","key":"10522_CR2","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/j.1478-3231.2012.02785.x","volume":"32","author":"M Senzolo","year":"2012","unstructured":"Senzolo M, Teresa MS, Rossetto V, Burra P, Cillo U, Boccagni P, et al. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int. 2012;32(6):919\u201327","journal-title":"Liver Int"},{"issue":"5","key":"10522_CR3","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1002\/hep.31915","volume":"74","author":"GM Knight","year":"2021","unstructured":"Knight GM, Clark J, Boike JR, Maddur H, Ganger DR, Talwar A, et al. TIPS for adults without cirrhosis with chronic mesenteric venous thrombosis and EHPVO refractory to standard-of-care therapy. Hepatology. 2021;74(5):2735\u20132744","journal-title":"Hepatology"},{"issue":"11","key":"10522_CR4","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1097\/TP.0000000000000729","volume":"99","author":"R Salem","year":"2015","unstructured":"Salem R, Vouche M, Baker T, Herrero JI, Caicedo JC, Fryer J, et al. Pretransplant portal vein recanalization-transjugular intrahepatic portosystemic shunt in patients with complete obliterative portal vein thrombosis. Transplantation. 2015;99(11):2347\u20132355","journal-title":"Transplantation"},{"issue":"4","key":"10522_CR5","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/hep.28429","volume":"63","author":"JR Kallini","year":"2016","unstructured":"Kallini JR, Gabr A, Kulik L, Ganger D, Lewandowski R, Thornburg B, et al. Noncirrhotic complete obliterative portal vein thrombosis: novel management using trans-splenic transjugular intrahepatic portosystemic shunt with portal vein recanalization. Hepatology. 2016;63(4):1387\u20131390","journal-title":"Hepatology"},{"issue":"4","key":"10522_CR6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jvir.2014.12.012","volume":"26","author":"A Habib","year":"2015","unstructured":"Habib A, Desai K, Hickey R, Thornburg B, Vouche M, Vogelzang RL, et al. Portal vein recanalization-transjugularintrahepatic portosystemic shunt using the transsplenic approach to achieve transplant candidacy in patients with chronic portal vein thrombosis. J Vasc Interv Radiol. 2015;26(4):499\u2013506","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"10522_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1053\/j.tvir.2016.01.006","volume":"19","author":"B Thornburg","year":"2016","unstructured":"Thornburg B, Desai K, Hickey R, Kulik L, Ganger D, Baker T, et al. Portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: technical considerations. Tech Vasc Interv Radiol. 2016;19(1):52\u201360","journal-title":"Tech Vasc Interv Radiol"},{"key":"10522_CR8","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver. Electronic address EEE. EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol 2016;64(1):179\u2013202","DOI":"10.1016\/j.jhep.2015.07.040"},{"issue":"7","key":"10522_CR9","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1136\/gutjnl-2019-320221","volume":"69","author":"D Tripathi","year":"2020","unstructured":"Tripathi D, Stanley AJ, Hayes PC, Travis S, Armstrong MJ, Tsochatzis EA, et al. Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension. Gut. 2020;69(7):1173\u20131192","journal-title":"Gut"},{"issue":"1","key":"10522_CR10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/hep.31646","volume":"73","author":"PG Northup","year":"2021","unstructured":"Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, et al. Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;73(1):366\u2013413","journal-title":"Hepatology"},{"issue":"4","key":"10522_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/1751-2980.12970","volume":"22","author":"Hepatobiliary Disease Study Group CSoGCMA","year":"2021","unstructured":"Hepatobiliary Disease Study Group CSoGCMA. Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai). J Dig Dis. 2021;22(4):176\u2013186","journal-title":"J Dig Dis"},{"issue":"9","key":"10522_CR12","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1097\/MEG.0b013e328338d995","volume":"22","author":"JM Perarnau","year":"2010","unstructured":"Perarnau JM, Baju A, D\u2019Alteroche L, Viguier J, Ayoub J. Feasibility and long-term evolution of TIPS in cirrhotic patients with portal thrombosis. Eur J Gastroenterol Hepatol. 2010;22(9):1093\u20131098","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"19","key":"10522_CR13","doi-asserted-by":"publisher","first-page":"5179","DOI":"10.12998\/wjcc.v9.i19.5179","volume":"9","author":"JB Zhang","year":"2021","unstructured":"Zhang JB, Chen J, Zhou J, Wang XM, Chen S, Chu JG, et al. Systematic review and meta-analysis of trans-jugular intrahepatic portosystemic shunt for cirrhotic patients with portal vein thrombosis. World J Clin Cases. 2021;9(19):5179\u20135190","journal-title":"World J Clin Cases"},{"issue":"1","key":"10522_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.dld.2010.06.001","volume":"43","author":"F Fanelli","year":"2011","unstructured":"Fanelli F, Angeloni S, Salvatori FM, Marzano C, Boatta E, Merli M, et al. Transjugular intrahepatic portosystemic shunt with expanded-polytetrafuoroethylene-covered stents in non-cirrhotic patients with portal cavernoma. Dig Liver Dis. 2011;43(1):78\u201384","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10522_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jhep.2010.06.029","volume":"54","author":"G Han","year":"2011","unstructured":"Han G, Qi X, He C, Yin Z, Wang J, Xia J, et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol. 2011;54(1):78\u201388","journal-title":"J Hepatol"},{"issue":"5","key":"10522_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1051-0443(99)70086-2","volume":"10","author":"T Yamagami","year":"1999","unstructured":"Yamagami T, Nakamura T, Tanaka O, Akada W, Takayama T, Maeda T. Transjugular intrahepatic portosystemic shunt after complete obstruction of portal vein. J Vasc Interv Radiol. 1999;10(5):575\u2013578","journal-title":"J Vasc Interv Radiol"},{"issue":"58","key":"10522_CR17","first-page":"1168","volume":"51","author":"EN Brountzos","year":"2004","unstructured":"Brountzos EN, Malagari K, Alexopoulou E, Nikolaou VE, Panagiotou I, Argyriou P, et al. Transjugular intrahepatic portosystemic shunt in cavernomatous portal vein occlusion. Hepatogastroenterology. 2004;51(58):1168\u20131171","journal-title":"Hepatogastroenterology"},{"issue":"4","key":"10522_CR18","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.jhep.2010.06.004","volume":"53","author":"R de Franchis","year":"2010","unstructured":"de Franchis R, Baveno VF. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010;53(4):762\u2013768","journal-title":"J Hepatol"},{"issue":"4","key":"10522_CR19","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","volume":"76","author":"R de Franchis","year":"2022","unstructured":"de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C, Baveno VIIF. Baveno VII\u2014renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959\u2013974","journal-title":"J Hepatol"},{"key":"10522_CR20","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver. Electronic address EEE and European Association for the Study of the L. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol 2018;69(2):406\u2013460","DOI":"10.1016\/j.jhep.2018.08.009"},{"issue":"2","key":"10522_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.dld.2013.08.138","volume":"46","author":"A Dell'Era","year":"2014","unstructured":"Dell\u2019Era A, Iannuzzi F, Fabris FM, Fontana P, Reati R, Grillo P, et al. Impact of portal vein thrombosis on the efficacy of endoscopic variceal band ligation. Dig Liver Dis. 2014;46(2):152\u2013156","journal-title":"Dig Liver Dis"},{"issue":"12","key":"10522_CR22","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1136\/gutjnl-2017-314634","volume":"67","author":"Y Lv","year":"2018","unstructured":"Lv Y, Qi X, He C, Wang Z, Yin Z, Niu J, et al. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial. Gut. 2018;67(12):2156\u20132168","journal-title":"Gut"},{"issue":"10","key":"10522_CR23","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1097\/MCG.0b013e31819706a4","volume":"43","author":"A Wils","year":"2009","unstructured":"Wils A, van der Linden E, van Hoek B, Pattynama PM. Transjugular intrahepatic portosystemic shunt in patients with chronic portal vein occlusion and cavernous transformation. J Clin Gastroenterol. 2009;43(10):982\u2013984","journal-title":"J Clin Gastroenterol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10522-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-023-10522-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10522-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T10:32:10Z","timestamp":1690626730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-023-10522-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10522"],"URL":"https:\/\/doi.org\/10.1007\/s12072-023-10522-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2282724\/v1","asserted-by":"object"}]},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]},"assertion":[{"value":"17 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jun Tie has no conflict of interest. Xiaoyuan Gou has no conflict of interest. Chuangye He has no conflict of interest. Kai Li has no conflict of interest. Xulong Yuan has no conflict of interest. Wenyuan Jia has no conflict of interest. Jing Niu has no conflict of interest. Na Han has no conflict of interest. Jiao Xu has no conflict of interest. Ying Zhu has no conflict of interest. Wenlan Wang has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Medical Ethics Committee of the First Affiliated Hospital of the Air Force Medical University (approval number: KY20222204-C-1) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}